H.C. Wainwright analyst Joseph Pantginis says Leerink this morning downgraded Compass Therapeutics (CMPX) saying the company’s biliary ...

H.C. Wainwright has downgraded Syros Pharmaceuticals (NASDAQ:SYRS) to neutral from buy, citing Tuesday’s announcement that a ...

H.C. Wainwright lowered the firm’s price target on Canoo (GOEV) to $2 from $4 and keeps a Buy rating on the shares post the Q3 report.

Ardelyx (NASDAQ:ARDX) shares were down over 5% after H.C. Wainwright downgraded the rating for the biopharmaceutical firm, ...

H.C. Wainwright reinstated coverage of Opus Genetics (IRD) with a Buy rating and $8 price target The firm believes inherited ...

H.C. Wainwright downgraded Syros Pharmaceuticals (SYRS) to Neutral from Buy with a price target of $1, down from $6, after ...

On Thursday, OPKO Health Inc (OPK) stock saw a modest uptick, ending the day at $1.62 which represents a slight increase of $0.02 or 1.25% from the prior close of $1.6. The stock opened at $1.58 and ...

On Thursday, Microvast Holdings Inc (MVST) stock saw a decline, ending the day at $0.78 which represents a decrease of $-0.02 or -2.50% from the prior close of $0.8. The stock opened at $0.93 and ...

MARA shares down as Q3 earnings miss estimates with lower revenue and adjusted loss, analysts maintain mixed views and price ...

H.C. Wainwright placed the firm’s Buy rating on Ocuphire Pharma (OCUP) under review saying the acquisition of Opus Genetics starts a new chapter. The views and opinions expressed herein are the ...

H.C. Wainwright initiated coverage of BitFuFu (FUFU) with a Buy rating and $7 price target BitFuFu is a cloud mining service provider, meaning the company hosts bitcoin mining machines in its ...

Ardelyx (NASDAQ:ARDX) shares were down over 5% after H.C. Wainwright downgraded the rating for the biopharmaceutical firm, saying that it anticipates a substantial drop in the company's kidney ...